All Stories

  1. Dual Antiplatelet Therapy or Aspirin after Coronary Bypass Surgery
  2. Refitting EuroSCORE II for 120-Day Mortality After Coronary Artery Bypass Grafting Using Nationwide Registry Data
  3. Types of Bleeding Following Mechanical Aortic Valve Replacement
  4. Long-Term Durability of the Sorin Soprano Aortic Bioprosthetic Valve—A Swedish Nationwide Study
  5. Ticagrelor and Aspirin or Aspirin Alone after Coronary Surgery for Acute Coronary Syndrome
  6. Reply to Xu et al
  7. Evidence for a Clinically Meaningful Effect of no-Touch Harvesting Technique on Vein Graft Patency—A Bayesian Reanalysis of the SWEDEGRAFT Trial
  8. Three-Year Follow-Up of the NOTION-2 Trial: TAVR Versus SAVR to Treat Younger Low-Risk Patients With Tricuspid or Bicuspid Aortic Stenosis
  9. Abstract 4368573: The Implication of Sex on Clinical Long-Term Outcomes After Surgical Aortic Valve Replacement
  10. 1-Year Outcomes of TAVR With ACURATE neo2 vs SAPIEN/Evolut
  11. Bleeding Complications from Chest Tube Treatment in Patients on Extracorporeal Membrane Oxygenation Support
  12. Sex-based differences after aortic valve surgery for infective endocarditis: a SWEDEHEART study
  13. Beyond the Heart: The Significance of Depression in Cardiac Surgery
  14. Mechanical Valves vs Bioprostheses: A Call to Reevaluate Our Biases and Commit to Data-Driven Valve Strategies
  15. Major Bleeding and Thromboembolic Events with the On-X Mechanical Aortic Valve Prosthesis: A SWEDEHEART Study
  16. Assessing the Safety, Feasibility, and Clinical Outcomes of a Fast-Track Strategy in Open Cardiac Surgery
  17. Sex difference in aortic root replacement with a stentless bioprosthesis
  18. Implications of pacemaker implantation after aortic valve surgery for endocarditis: a nationwide study
  19. Early Creatinine Changes After Aortic Valve Replacement and Late Survival, Heart Failure, and Chronic Kidney Disease in a National Registry
  20. Have Biomarkers Been Evaluated Correctly?
  21. No-touch vein grafts in coronary artery bypass surgery: a registry-based randomized clinical trial
  22. Abstract 4137441: Online Cognitive Behavioral Therapy Targeting Psychological Distress Following Open Heart Surgery: An Uncontrolled Pilot Study
  23. Sex differences and long-term clinical outcomes after transcatheter aortic valve replacement: A SWEDEHEART study
  24. Predicted prosthesis–patient mismatch and long-term clinical outcomes after transcatheter aortic valve replacement: A SWEDEHEART study
  25. Long-Term Outcomes Associated With Permanent Pacemaker Implantation in Low-Risk Surgical Aortic Valve Replacement
  26. Bleeding and long-term survival after lung resections: nationwide observational cohort study
  27. Bleeding in minimally invasive versus conventional aortic valve replacement
  28. Skeletonized Versus Pedicled Harvesting of the Internal Thoracic Artery and Long‐Term Clinical Outcomes in Coronary Artery Bypass Surgery
  29. The effect of continuous bilateral parasternal block with lidocaine on patient-controlled analgesia opioid requirement and recovery after open heart surgery: a double-blind randomised controlled trial
  30. Transcatheter aortic valve implantation in low-risk tricuspid or bicuspid aortic stenosis: the NOTION-2 trial
  31. Comparative Long-Term Clinical Performance of Mechanical Aortic Valve Prostheses
  32. Uniportal video-assisted thoracic surgery: segmentectomy versus lobectomy—early outcomes
  33. Self-reported preoperative depressive symptoms and survival after cardiac surgery
  34. Prosthetic Valve Endocarditis After Aortic Valve Replacement With Bovine Versus Porcine Bioprostheses
  35. Association of Preoperative Renal-Resistive Index With Long-term Renal and Cardiovascular Outcomes After Cardiac Surgery
  36. Abstract 15691: Permanent Pacemaker Implantation After Aortic Valve Surgery for Infective Endocarditis Was Associated With an Increased Risk of Heart Failure
  37. TCT-192 Predicted Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement Was Not Associated With Long-Term Clinical Outcomes
  38. Surgical ventricular reconstruction in ischemic heart disease
  39. Reply
  40. Extrapleural infusion of levobupivacaine versus levobupivacaine‐sufentanil‐adrenaline after video‐assisted thoracoscopic surgery (VATS): A randomised controlled trial
  41. Aortic Valve Replacement With Mechanical Valves vs Perimount Bioprostheses in 50- to 69-Year-Old Patients
  42. Dual or single antiplatelet therapy after coronary surgery for acute coronary syndrome (TACSI trial): Rationale and design of an investigator-initiated, prospective, multinational, registry-based randomized clinical trial
  43. Quality of life and functional status after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: A Swedish single‐center study
  44. Effect of Prosthesis-Patient Mismatch on Long-Term Clinical Outcomes After Bioprosthetic Aortic Valve Replacement
  45. Survival after aortic root replacement with a stentless xenograft is determined by patient characteristics
  46. Sex and Permanent Pacemaker Implantation After Surgical Aortic Valve Replacement
  47. Reply
  48. Survival Probability and Survival Benefit Associated With Primary Prevention Implantable Cardioverter‐Defibrillator Generator Changes
  49. Surgery for endocarditis in patients with bicuspid aortic valves
  50. Parasternal After Cardiac Surgery (PACS): a prospective, randomised, double-blinded, placebo-controlled trial study protocol for evaluating a continuous bilateral parasternal block with lidocaine after open cardiac surgery through sternotomy
  51. Critical appraisal of a registry study: aortic valve replacement in patients aged 50–69 years
  52. Socioeconomic Status and Risk of Bleeding After Mechanical Aortic Valve Replacement
  53. Unravelling the Difference Between Men and Women in Post-CABG Survival
  54. Association of residual pulmonary hypertension with survival after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension
  55. The Association Between Acute Kidney Injury and Mortality After Coronary Artery Bypass Grafting Was Similar in Women and Men
  56. Stress ulcer prophylaxis in the cardiac surgery intensive care unit
  57. Comparison of Long-term Performance of Bioprosthetic Aortic Valves in Sweden From 2003 to 2018
  58. Risk of depression after coronary artery bypass grafting: a SWEDEHEART population-based cohort study
  59. Statin Therapy and Intensity: Prognosis in Patients with Myocardial Injury
  60. Cause of Death After Surgical Aortic Valve Replacement: SWEDEHEART Observational Study
  61. Permanent pacemaker implantation after On-X surgical aortic valve replacement: SWEDEHEART observational study
  62. Sex and survival following pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a Scandinavian observational cohort study
  63. Surgery for Endocarditis in Intravenous Drug Users
  64. Long-term Outcomes Associated With Permanent Pacemaker Implantation After Surgical Aortic Valve Replacement
  65. Response
  66. Sex and Survival After Surgery for Lung Cancer
  67. Relative survival after aortic valve surgery in patients with bicuspid aortic valves
  68. Porcine vs Bovine Bioprosthetic Aortic Valves: Long-Term Clinical Results
  69. Treatment With Cardiovascular Medications: Prognosis in Patients With Myocardial Injury
  70. Reporting on the development of risk prediction models
  71. Comorbidities and cause-specific outcomes in heart failure across the ejection fraction spectrum: A blueprint for clinical trial design
  72. Household disposable income and long-term survival after pulmonary resections for lung cancer
  73. Preoperative disturbances of glucose metabolism and mortality after coronary artery bypass grafting
  74. No-touch saphenous vein grafts in coronary artery surgery (SWEDEGRAFT): Rationale and design of a multicenter, prospective, registry-based randomized clinical trial
  75. Causes of Death in Patients With Acute and Chronic Myocardial Injury
  76. Causes of death in relation to stable troponin levels including chronic myocardial injury
  77. Life expectancy after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a Swedish single‐center study
  78. Erratum to video-assisted thoracoscopic versus open thoracotomy lobectomy: a Swedish nationwide cohort study
  79. Modeling defibrillation benefit for survival among cardiac resynchronization therapy defibrillator recipients
  80. Death in low-risk cardiac surgery revisited
  81. PROGNOSIS IN PATIENTS WITH MYOCARDIAL INJURY IN RELATION TO TREATMENT WITH CARDIOVASCULAR MEDICATION
  82. The Influence of Indication on Intermediate-term Survival after Full Root Freestyle Implantation: A Multicenter Study
  83. Uniportal versus multiportal video-assisted thoracic surgery for lung cancer
  84. P3439Causes of death in patients with chronic myocardial injury
  85. P1543Causes of death in patients with myocardial infarction, and non-ischemic myocardial injury
  86. Coronary Artery Bypass Grafting in Women 50 Years or Younger
  87. Loss in Life Expectancy After Surgical Aortic Valve Replacement
  88. Glycated Hemoglobin A1c Levels in Type 1 Diabetes Mellitus and Outcomes After Myocardial Infarction
  89. ABO blood type and risk of porcine bioprosthetic aortic valve degeneration: SWEDEHEART observational cohort study
  90. Initial results from a randomized trial in video-assisted versus open thoracic surgery
  91. Longitudinal changes in depression screening results in cardiac surgery patients
  92. Association of heart rate with mortality in sinus rhythm and atrial fibrillation in heart failure with preserved ejection fraction
  93. Heart failure and the risk of acute kidney injury in relation to ejection fraction in patients undergoing coronary artery bypass grafting
  94. Relation of Chronic Myocardial Injury and Non-ST-Segment Elevation Myocardial Infarction to Mortality
  95. Continuous surgical multi-level extrapleural block for video-assisted thoracoscopic surgery: a retrospective study assessing its efficacy as pain relief following lobectomy and wedge resection
  96. Frailty—a strong risk marker in heart surgery?
  97. Right ventricular mechanics and contractility after aortic valve replacement surgery: a randomised study comparing minimally invasive versus conventional approach
  98. Surgery for pulmonary metastases from colorectal cancer: survival and prognostic factors
  99. Video-assisted thoracoscopic versus open thoracotomy lobectomy: a Swedish nationwide cohort study
  100. Survival after Aortic Valve Replacement with Bovine or Porcine Valve Prostheses: A Systematic Review and Meta-Analysis
  101. Depression Screening in Cardiac Surgery Patients
  102. Weekday and Survival After Pulmonary Resections for Lung Cancer
  103. SURVIVAL IN PATIENTS WITH CHEST PAIN AND STABLE HIGH-SENSITIVITY CARDIAC TROPONIN T LEVELS VERSUS PATIENTS WITH NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
  104. Validity of the Swedish Cardiac Surgery Registry
  105. Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure
  106. Response by Glaser et al to Letter Regarding Article, “Prosthetic Valve Endocarditis After Surgical Aortic Valve Replacement”
  107. Comparison of right ventricular function after ministernotomy and full sternotomy aortic valve replacement: a randomized study
  108. Vancomycin prophylaxis and acute kidney injury after cardiac surgery
  109. Reply to Sartipy
  110. Bilateral Versus Single Internal Thoracic Artery Grafts
  111. Long-term survival after surgery for pulmonary metastases from colorectal cancer: an observational cohort study
  112. Correction
  113. Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes
  114. PCI Versus CABG in Patients With Type 1 Diabetes and Multivessel Disease
  115. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction
  116. Hypo‐Attenuated Leaflet Thickening and Reduced Leaflet Motion in Sutureless Bioprosthetic Aortic Valves
  117. Prosthetic Valve Endocarditis After Surgical Aortic Valve Replacement
  118. Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators
  119. Weekday and Survival After Cardiac Surgery—A Swedish Nationwide Cohort Study in 106 473 Patients
  120. Association of Donor Age and Sex With Survival of Patients Receiving Transfusions
  121. Recurrence rate after thoracoscopic surgery for primary spontaneous pneumothorax
  122. Acute kidney injury—an overview of diagnostic methods and clinical management
  123. Loss to Follow-Up?
  124. Early Postpartum Mitral Valve Thrombosis Requiring Extra Corporeal Membrane Oxygenation before Successful Valve Replacement
  125. Self-Reported Physical Quality of Life Before Thoracic Operations Is Associated With Long-Term Survival
  126. Long-Term Risk of Ischemic Stroke After the Cox-Maze III Procedure for Atrial Fibrillation
  127. Late Survival After Aortic Valve Replacement in Patients With Moderately Reduced Kidney Function
  128. Sex-Discordant Blood Transfusions and Survival After Cardiac Surgery: Table.
  129. Association between preoperative depression and long-term survival following coronary artery bypass surgery — A systematic review and meta-analysis
  130. Heart failure in Tanzania and Sweden: Comparative characterization and prognosis in the Tanzania Heart Failure (TaHeF) study and the Swedish Heart Failure Registry (SwedeHF)
  131. Preoperative Renal Resistive Index Predicts Risk of Acute Kidney Injury in Patients Undergoing Cardiac Surgery
  132. Survival After Coronary Artery Bypass Grafting in Patients With Preoperative Heart Failure and Preserved vs Reduced Ejection Fraction
  133. Estimated glucose disposal rate and long-term survival in type 2 diabetes after coronary artery bypass grafting
  134. Early postpartum mitral valve thrombosis requiring extra corporeal membrane oxygenation before successful valve replacement
  135. Venous Cannula Positioning in Arterial Deoxygenation During Veno-Arterial Extracorporeal Membrane Oxygenation-A Simulation Study and Case Report
  136. Aortic valve replacement in middle-aged patients: Is the increased use of bioprostheses justified?
  137. Letter in response to “Assessing the association of diabetes mellitus with acute kidney injury after coronary artery bypass grafting” by Fu-Shan Xue et al
  138. Reply to Letter From Sebastian J. Baxter and Siax I. Jaggar Entitled, "Teicoplanin, Acute Kidney Injury and Surgical-Site Infection in Cardiac Surgery"
  139. Relationship between preoperative hemoglobin A1c levels and long-term mortality after coronary artery bypass grafting in patients with type 2 diabetes mellitus
  140. Letter in response to manuscript IJC-D-15-04003 entitled “Comment on antidepressant use in cardiovascular diseases” by Dr. Onur Durmaz
  141. Reply
  142. Aortic valve replacement with mechanical vs. biological prostheses in patients aged 50–69 years
  143. Abstract 17564: Long-term Risk of Stroke in Patients With Type 1 and Type 2 Diabetes Following Coronary Artery Bypass Grafting
  144. Long-Term Risk of Stroke in Patients With Type 1 and Type 2 Diabetes Following Coronary Artery Bypass Grafting
  145. Type 1 and type 2 diabetes mellitus and risk of acute kidney injury after coronary artery bypass grafting
  146. Do socioeconomic factors modify the association between preoperative antidepressant use and survival following coronary artery bypass surgery?
  147. Acute Kidney Injury After Surgical AVR and Long-Term Risk of Death and End-Stage Renal Disease
  148. Red Blood Cell Concentrate Storage and Survival After Cardiac Surgery
  149. Household Disposable Income and Long-Term Survival After Cardiac Surgery
  150. An Adjusted Calculation Model Allows for Reduced Protamine Doses without Increasing Blood Loss in Cardiac Surgery
  151. Prognostic Significance of Resting Heart Rate and Use of β-Blockers in Atrial Fibrillation and Sinus Rhythm in Patients With Heart Failure and Reduced Ejection FractionCLINICAL PERSPECTIVE
  152. Glycemic Control in Type 1 Diabetes and Long-Term Risk of Cardiovascular Events or Death After Coronary Artery Bypass Grafting
  153. Antibiotic Prophylaxis by Teicoplanin and Risk of Acute Kidney Injury in Cardiac Surgery
  154. Long-Term Prognosis in Patients With Type 1 and 2 Diabetes Mellitus After Coronary Artery Bypass Grafting
  155. Coronary Artery Bypass Grafting in Patients 50 Years or Younger: A Swedish Nationwide Cohort Study
  156. Aortic valve replacement through full sternotomy with a stented bioprosthesis versus minimally invasive sternotomy with a sutureless bioprosthesis
  157. Ministernotomy Versus Full Sternotomy Aortic Valve Replacement With a Sutureless Bioprosthesis: A Multicenter Study
  158. Ministernotomy versus Full Sternotomy Aortic Valve Replacement with a Sutureless Aortic Bioprosthesis: An European Multicenter Registry
  159. Immediate outcome after sutureless versus transcatheter aortic valve replacement
  160. Acute Kidney Injury After Coronary Artery Bypass Grafting and Long-Term Risk of End-Stage Renal Disease
  161. Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for heart transplantation
  162. Relation of Major Depression to Survival After Coronary Artery Bypass Grafting
  163. Early and intermediate outcome after aortic valve replacement with a sutureless bioprosthesis: Results of a multicenter study
  164. Late haemodynamic performance and survival after aortic valve replacement with the Mosaic bioprosthesis
  165. Assessment of a University of California, Los Angeles 4-Variable Risk Score for Advanced Heart Failure
  166. Guideline-directed medical therapy for secondary prevention after coronary artery bypass grafting in patients with depression
  167. Late Survival After Aortic Valve Replacement With the Perimount Versus the Mosaic Bioprosthesis
  168. Long-term Cardiovascular Outcomes in Patients With Chronic Kidney Disease Undergoing Coronary Artery Bypass Graft Surgery for Acute Coronary Syndromes
  169. Acute kidney injury after coronary artery bypass grafting and long-term risk of myocardial infarction and death
  170. Bilateral versus Single Internal Mammary Coronary Artery Bypass Grafting in Sweden from 1997–2008
  171. Freestyle xenograft for aortic valve endocarditis
  172. Minimal Changes in Postoperative Creatinine Values and Early and Late Mortality and Cardiovascular Events After Coronary Artery Bypass Grafting
  173. Acute Kidney Injury after Valvular Heart Surgery and Early Changes in Cardiac Function and Structure
  174. Predicting survival in heart failure: validation of the MAGGIC heart failure risk score in 51 043 patients from the Swedish Heart Failure Registry
  175. Long-Term Survival After Off-Pump Coronary Artery Bypass Surgery: A Swedish Nationwide Cohort Study
  176. Relation Between Preoperative Renal Dysfunction and Cardiovascular Events (Stroke, Myocardial Infarction, or Heart Failure or Death) Within Three Months of Isolated Coronary Artery Bypass Grafting
  177. Better survival after lung cancer surgery in high-volume hospitals
  178. Acute kidney injury and long-term risk of stroke after coronary artery bypass surgery
  179. Cardiovascular medication in relation to renal function after coronary artery bypass surgery
  180. Response to letter by Balta et al regarding “Renal dysfunction and long-term risk of heart failure after coronary artery bypass grafting”
  181. Antidepressant use before coronary artery bypass surgery is associated with long-term mortality
  182. Renal dysfunction and long-term risk of ischemic and hemorrhagic stroke following coronary artery bypass grafting
  183. Peripheral Extracorporeal Membrane Oxygenation as Short-Term Right Ventricular Support After HeartWare Left Ventricular Assist Device Implantation
  184. HeartWare left ventricular assist device thrombosis in aspirin non-responder
  185. Nodal upstaging after thoracoscopic versus open lobectomy
  186. Renal dysfunction and long-term risk of heart failure after coronary artery bypass grafting
  187. Survival in patients with acute kidney injury requiring dialysis after coronary artery bypass grafting
  188. Long-Term Survival After Operations for Native and Prosthetic Valve Endocarditis
  189. Guided or nonguided endocardectomy during surgical ventricular reconstruction?
  190. Blood in, blood out: left ventricular pseudoaneurysm following mitral valve endocarditis
  191. Acute Kidney Injury Following Coronary Artery Bypass Surgery and Long-term Risk of Heart Failure
  192. Surgery for early stage small cell lung cancer
  193. Outcomes after thoracoscopic versus open lobectomy
  194. Quality of life six months after lung cancer surgery is associated with long-term survival
  195. Clinical Nephrology - Epidemiology II
  196. Predictors of Postoperative Quality of Life after Surgery for Lung Cancer
  197. Associations Between Changes in Quality of Life and Survival After Lung Cancer Surgery
  198. Surgical management of ventricular arrhythmias
  199. Long-term health-related quality of life following surgery for lung cancer
  200. 16S rDNA sequencing of valve tissue improves microbiological diagnosis in surgically treated patients with infective endocarditis
  201. Death in low-risk cardiac surgery: Stockholm experience
  202. Influence of gender on quality of life after lung surgery☆
  203. Changes in Quality of Life After Lung Surgery in Old and Young Patients: Are They Similar?
  204. Survival and Quality of Life in Cardiac Surgery Patients With Prolonged Intensive Care
  205. Quality of life ten years after surgery for Acute Coronary Syndrome or stable angina
  206. Prospective population-based study comparing quality of life after pneumonectomy and lobectomy☆
  207. Aprotinin reduces the antiplatelet effect of clopidogrel
  208. Quality of life ten years after surgery for Acute Coronary Syndrome or stable angina
  209. Aprotinin is Not Associated With Postoperative Renal Impairment After Primary Coronary Surgery
  210. Hemodynamics at rest do not match clinical improvement after surgical ventricular restoration
  211. Surgery for ventricular tachycardia and left ventricular aneurysm provides arrhythmia control
  212. Surgery for ventricular tachycardia in patients undergoing surgical ventricular restoration: The Karolinska approach
  213. Changes in B-type natriuretic peptides after surgical ventricular restoration
  214. Improved Health-Related Quality of Life and Functional Status After Surgical Ventricular Restoration
  215. Edge-to-Edge Mitral Repair Without Annuloplasty in Combination With Surgical Ventricular Restoration
  216. Use of conventional ECG electrodes for depth of anaesthesia monitoring using the cerebral state index: a clinical study in day surgery
  217. Surgery for ventricular tachycardia in patients undergoing surgical ventricular restoration
  218. Letter by van der Linden et al Regarding Article, "Effect of Clopidogrel Premedication in Off-Pump Cardiac Surgery: Are We Forfeiting the Benefits of Reduced Hemorrhagic Sequelae?"
  219. Risk factors for mortality and hospital re-admission after surgical ventricular restoration
  220. Cardiac Rupture During Vacuum-Assisted Closure Therapy
  221. Aorto-Carotid Bypass for Cerebral Malperfusion after Aortic Dissection Surgery: A Case Report
  222. Left Ventricular Reconstruction as an Alternative to Heart Transplantation: A Case Report
  223. Implantable cardioverter-defibrillator after left ventricular reconstruction?
  224. Surgery for Ventricular Tachycardia in Patients Undergoing Left Ventricular Reconstruction by the Dor Procedure
  225. Aprotinin Reduces Bleeding and Blood Product Use in Patients Treated With Clopidogrel Before Coronary Artery Bypass Grafting
  226. Aprotinin Decreases Postoperative Bleeding and Number of Transfusions in Patients on Clopidogrel Undergoing Coronary Artery Bypass Graft Surgery
  227. The Dor procedure for left ventricular reconstruction. Ten-year clinical experience
  228. Successful off pump coronary artery bypass grafting in a patient with an undiagnosed pheochromocytoma